CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) unveiled three new advanced deep learning image processing and reconstruction solutions as a part of its Effortless Recon DL portfolio at the ...
Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Genitourinary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback